CN111918971B - 利用化学确定的重组核小体定量核小体修饰 - Google Patents

利用化学确定的重组核小体定量核小体修饰 Download PDF

Info

Publication number
CN111918971B
CN111918971B CN201980016349.5A CN201980016349A CN111918971B CN 111918971 B CN111918971 B CN 111918971B CN 201980016349 A CN201980016349 A CN 201980016349A CN 111918971 B CN111918971 B CN 111918971B
Authority
CN
China
Prior art keywords
nucleosome
modifications
recombinant
histone
library
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201980016349.5A
Other languages
English (en)
Chinese (zh)
Other versions
CN111918971A (zh
Inventor
马尔蒂斯·威廉·考尔斯
马修·F·韦利汉
安德烈亚·L·约翰斯通
迈克尔-克里斯托弗·基奥
孙如文
内森·W·哈勒
马修·R·马龙德
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
EPSILON
Original Assignee
EPSILON
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by EPSILON filed Critical EPSILON
Publication of CN111918971A publication Critical patent/CN111918971A/zh
Application granted granted Critical
Publication of CN111918971B publication Critical patent/CN111918971B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6875—Nucleoproteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6804—Nucleic acid analysis using immunogens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6811—Selection methods for production or design of target specific oligonucleotides or binding molecules
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/49—Blood
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/31—Endoribonucleases active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters (3.1.31)
    • C12Y301/31001—Micrococcal nuclease (3.1.31.1)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2440/00—Post-translational modifications [PTMs] in chemical analysis of biological material
    • G01N2440/18—Post-translational modifications [PTMs] in chemical analysis of biological material citrullination

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Ecology (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
CN201980016349.5A 2018-03-01 2019-03-01 利用化学确定的重组核小体定量核小体修饰 Active CN111918971B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862637066P 2018-03-01 2018-03-01
US62/637,066 2018-03-01
PCT/US2019/020283 WO2019169263A1 (en) 2018-03-01 2019-03-01 Quantification of nucleosome modifications using chemically-defined recombinant nucleosomes

Publications (2)

Publication Number Publication Date
CN111918971A CN111918971A (zh) 2020-11-10
CN111918971B true CN111918971B (zh) 2024-09-03

Family

ID=67805943

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201980016349.5A Active CN111918971B (zh) 2018-03-01 2019-03-01 利用化学确定的重组核小体定量核小体修饰

Country Status (10)

Country Link
US (2) US10787697B2 (cg-RX-API-DMAC7.html)
EP (2) EP3759249B1 (cg-RX-API-DMAC7.html)
JP (1) JP7376493B2 (cg-RX-API-DMAC7.html)
CN (1) CN111918971B (cg-RX-API-DMAC7.html)
AU (1) AU2019228625B2 (cg-RX-API-DMAC7.html)
CA (1) CA3091807A1 (cg-RX-API-DMAC7.html)
DK (2) DK4215621T3 (cg-RX-API-DMAC7.html)
ES (2) ES2960550T3 (cg-RX-API-DMAC7.html)
FI (2) FI3759249T3 (cg-RX-API-DMAC7.html)
WO (1) WO2019169263A1 (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230003735A1 (en) * 2019-12-02 2023-01-05 Belgian Volition Srl Use of cell free nucleosomes as biomarkers
US12636417B2 (en) 2020-09-21 2026-05-26 Belgian Volition Srl Device for inline monitoring of free nucleosomes in blood
CN112359092B (zh) * 2020-10-22 2023-09-19 中国农业科学院农业基因组研究所 一种基因组短片段文库的构建方法
CA3195344A1 (en) * 2020-11-02 2022-05-05 Matthew R. MARUNDE Improved assays to quantify chromatin targets using antibody-targeted enzyme digestion
GB202108185D0 (en) * 2021-06-08 2021-07-21 Belgian Volition Sprl Standardisation of nucleosome assays using biologically derived calibrants
WO2023159045A1 (en) * 2022-02-15 2023-08-24 Epicypher, Inc. Engineered recombinant protein-binding domains as detection reagents
WO2024042208A1 (en) * 2022-08-25 2024-02-29 Belgian Volition Srl Method for the detection of dementia
EP4602370A1 (en) * 2022-10-12 2025-08-20 Epicypher, Inc. High efficiency antibodies for chromatin targets
EP4639173A1 (en) * 2022-12-19 2025-10-29 Belgian Volition SRL Calibration
EP4689160A1 (en) * 2023-04-03 2026-02-11 Belgian Volition SRL Recombinant nucleosome materials

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107002289A (zh) * 2014-02-03 2017-08-01 芝加哥大学 用于定量评价dna‑蛋白质复合物密度的组合物和方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1008748A (en) 1910-06-15 1911-11-14 Christian Keene Snavely Shade-roller.
GB0319376D0 (en) * 2003-08-18 2003-09-17 Chroma Therapeutics Ltd Histone modification detection
WO2011016869A1 (en) 2009-08-06 2011-02-10 Kamran Tahamtanzadeh Methods and compositions for drug discovery
EP2621942A4 (en) * 2010-09-29 2015-01-21 Gen Hospital Corp MEANS FOR PROVIDING CONTROLS AND STANDARDS FOR IMMUNE PRECIPITATION ASSAYS
GB201115099D0 (en) 2011-09-01 2011-10-19 Belgian Volition Sa Method for detecting nucleosomes
GB201115095D0 (en) * 2011-09-01 2011-10-19 Singapore Volition Pte Ltd Method for detecting nucleosomes containing nucleotides
GB201115098D0 (en) * 2011-09-01 2011-10-19 Belgian Volition Sa Method for detecting nucleosomes containing histone variants
EP2859139B1 (en) 2012-06-06 2018-08-01 The Trustees Of Princeton University Dna barcoding of designer mononucleosome and chromatin array libraries for the profiling of chromatin readers, writers, erasers, and modulators thereof
US9745384B2 (en) * 2012-12-20 2017-08-29 The Brigham And Women's Hospital, Inc. Peptides useful for modulating histone demethylase function
GB201303575D0 (en) * 2013-02-28 2013-04-10 Singapore Volition Pte Ltd Method for detecting histone modifications in nucleosomes
GB201400522D0 (en) * 2014-01-13 2014-02-26 Proteros Biostructure Gmbh Nucleosome substrate assays
GB201511512D0 (en) 2015-07-01 2015-08-12 Singapore Volition Pte Ltd Use of cell-free nucleosomes as biomarkers
WO2017034970A1 (en) * 2015-08-21 2017-03-02 The General Hospital Corporation Combinatorial single molecule analysis of chromatin
GB201518665D0 (en) * 2015-10-21 2015-12-02 Singapore Volition Pte Ltd Method for enrichment of cell free nucleosomes
EP3371601A1 (en) 2015-11-05 2018-09-12 Epizyme Inc Flow cytometry for monitoring histone h3 methylation status

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107002289A (zh) * 2014-02-03 2017-08-01 芝加哥大学 用于定量评价dna‑蛋白质复合物密度的组合物和方法

Also Published As

Publication number Publication date
US10787697B2 (en) 2020-09-29
DK4215621T3 (da) 2025-08-04
JP2021515888A (ja) 2021-06-24
CN111918971A (zh) 2020-11-10
EP4215621A1 (en) 2023-07-26
CA3091807A1 (en) 2019-09-06
EP3759249B1 (en) 2023-08-30
ES3036655T3 (en) 2025-09-23
EP4215621B1 (en) 2025-05-28
US20200071745A1 (en) 2020-03-05
ES2960550T3 (es) 2024-03-05
AU2019228625A1 (en) 2020-09-03
FI3759249T3 (fi) 2023-10-11
US20210010058A1 (en) 2021-01-14
FI4215621T3 (fi) 2025-07-28
EP3759249A1 (en) 2021-01-06
US12104199B2 (en) 2024-10-01
DK3759249T3 (da) 2023-10-30
JP7376493B2 (ja) 2023-11-08
WO2019169263A1 (en) 2019-09-06
AU2019228625B2 (en) 2024-11-07
EP3759249A4 (en) 2021-11-24

Similar Documents

Publication Publication Date Title
US12104199B2 (en) Quantification of nucleosome modifications using chemically-defined recombinant nucleosomes
JP2021515888A5 (cg-RX-API-DMAC7.html)
US20230407406A1 (en) Methods for Quantification of Nucleosome Modifications and Mutations at Genomic Loci and Clinical Applications Thereof
ES2808651T3 (es) Composiciones y métodos para la evaluación cuantitativa de la densidad del complejo de ADN-proteína
US20260035731A1 (en) Dna-barcoded nucleosomes for chromatin mapping assays
Sharma et al. Genetically encoded fluorescent reporter for polyamines
Brás et al. Huntington disease
HK40098174A (en) Quantification of nucleosome modifications using chemically-defined recombinant nucleosomes
HK40098174B (en) Quantification of nucleosome modifications using chemically-defined recombinant nucleosomes
HK40045196A (en) Quantification of nucleosome modifications using chemically-defined recombinant nucleosomes
HK40045196B (en) Quantification of nucleosome modifications using chemically-defined recombinant nucleosomes
WO2014185549A1 (ja) 細胞のエピジェネティックな情報を得る方法、細胞の特性を判定する方法、薬剤感受性を判断するまたは薬剤若しくは免疫療法剤の種類を選択する方法、疾患の診断方法、並びに自己複製ベクター、アッセイキットおよび分析装置
US20220049311A1 (en) Chromatin mapping assays and kits using long-read sequencing

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant